登记Id

PA451954

药物名称(英)

zidovudine

通用名称

AZT

商品名称

"Apo-Zidovudine","Azidothymidine","Aztec","Compound S","Novo-Azt","Retrovir","Zidovudine EP III"

品牌组合

"Combivir (Lamivudine + Zidovudine)","Trizivir (Abacavir sulfate + Lamivudine + Zidovudine)"

类型(英)

Prodrug

类型

前药

交叉引用

"BindingDB:50002692","Canadian Drugs Product Database:01946323","ChEBI:CHEBI:10110","Chemical Abstracts Service:30516-87-1","ChemSpider:32555","ClinicalTrials.gov:NCT00098293","ClinicalTrials.gov:NCT01386970","DrugBank:DB00495","FDA Drug Label at DailyMed:a524da34-b315-452c-5ab3-e86bd9615e92","KEGG Compound:C07210","KEGG Drug:D00413","National Drug Code Directory:0173-0107-93","PubChem Compound:35370","PubChem Substance:46508240","PubChem Substance:7847479","Therapeutic Targets Database:DAP000701","URL:http://en.wikipedia.org/wiki/Zidovudine"

简化分子线性输入规范

CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]

键

InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1

剂量指南

No

外部词汇

"ATC:J05AF01(zidovudine)","UMLS:C0043474(Zidovudine)","RxNorm:11413(Zidovudine)","NDFRT:N0000147622(ZIDOVUDINE)"

RxNorm 标识符

11413

ATC 标识符

J05AF01

化合物标识符

35370